Atherosclerosis and Lipoproteins |
Methods and Results Sixteen-week-old, male apolipoprotein Edeficient mice were treated with injections of recombinant leptin (125 µg per day IP; n=10) or vehicle (n=10) for 4 weeks. Leptin treatment resulted in reduced epididymal fat (352±30.7 versus 621±61.5 mg; P=0.005) and fasting insulin (0.57±0.25 versus 1.7±0.22 ng/mL; P=0.014). Despite these metabolic benefits, leptin treatment resulted in an increase in atherosclerosis (8.0±0.95% versus 5.4±0.59% lesion surface coverage; P<0.05). Leptin treatment also resulted in a shortened time to occlusive thrombosis after vascular injury (21±2.1 versus 34.6±5.4 minutes; P=0.045).
Conclusions These studies indicate that exogenous leptin promotes atherosclerosis and thrombosis and support the concept that elevations of leptin may increase the risk for cardiovascular disease.
Key Words: obesity vascular smooth muscle arterial injury adipocyte adipokines
This article has been cited by other articles:
![]() |
P. F. Bodary, Y. Shen, M. Ohman, K. L. Bahrou, F. B. Vargas, S. S. Cudney, K. J. Wickenheiser, M. G. Myers Jr, and D. T. Eitzman Leptin Regulates Neointima Formation After Arterial Injury Through Mechanisms Independent of Blood Pressure and the Leptin Receptor/STAT3 Signaling Pathways Involved in Energy Balance Arterioscler Thromb Vasc Biol, January 1, 2007; 27(1): 70 - 76. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |